25 Jun 2015

Vermox Suspension (Mebendazole) - United Kingdom

ATC: P02CA
ANTIPARASITIC PRODUCTS
ANTHELMINTICS
ANTINEMATODAL AGENTS
BENZIMIDAZOLE DERIVATIVES
Vermox Suspension

Generic Matches for Mebendazole (2)
Vermox Tablets
VERMOX Suspension

Last Updated on 25 Jun 2015 by EPG Health Media Staff

Suggest content to an epgonline.org editor - or let us know about a mistake you have spotted on this page

Vermox Suspension Indication

Broad spectrum gastrointestinal anthelmintic indicated for the treatment of:

Enterobius vermicularis (threadworm/pinworm)

Oxyuris vermicularis

Trichuris trichuria (whipworm)

Ascaris lumbricoides (large roundworm)

Ancylostoma duodenale (common hookworm)

Necator americanus (American hookworm)

There is no evidence that Vermox is effective in the treatment of cysticercosis.

 

Vermox Suspension Generic Name

Mebendazole

Type

POM

Summary Product Characteristics (SPCs) Links
SPC - Vermox 100 mg/5 ml oral suspension (external site)

Related Learning Zones

CSU Knowledge Centre and CME

CSU Knowledge Centre and CME

This Knowledge Centre is intended for allergists, immunologists, dermatologists and other healthcare professionals involved in the treatment and management of Chronic Spontaneous Urticaria (CSU). In the Knowledge Centre, you will find a disease overview, symposium highlights platform, video channel and additional resources including an events calendar and useful external links. This resource has been given a whole new look and feel, intended to improve accessibility and visual appeal. Recent content additions include a frequently asked questions section, case studies from urticaria experts Professor Christian Vestergaard and Professor Torsten Zuberbier and information on the TARGET My Hives app.

IL-17A in Psoriasis Knowledge Centre

IL-17A in Psoriasis Knowledge Centre

IL-17A in Psoriasis is intended for healthcare professionals involved in the treatment and management of patients with psoriasis. This resource has been developed primarily to discuss the role of the IL-17 pathway in the pathogenesis of psoriasis and the therapeutic potential of treatments directed towards IL-17A. Users can expect to find sections containing expert videos, clinical slide decks, congress highlights, key publications and links to useful resources.

This resource has been developed in collaboration with Novartis Pharma AG.

Vermox Suspension Marketing Information

Vermox Suspension Generic Name
Mebendazole
Marketing Company
Janssen-Cilag Ltd
Drug Type
POM
Date of Issue, Marketing Authority 17/11/1977

Related Drugs - Tropical Medicine

Back to top